• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety

Medway NHS Foundation Trust Seeks to Increase Clinical Trials and Improve Collaborative Research by Partnering with TriNetX

Mar 7, 2019 | Press Releases

Cambridge, MA, March 7, 2019 — Medway NHS Foundation Trust, part of the U.K.’s National Institute for Health Research Clinical Research Network Kent Surrey and Sussex (CRN KSS), announced they have joined the TriNetX global health research network in an effort to...

Houston Methodist Hospital Joins TriNetX to Enhance Study Feasibility, Academic Collaboration, and Participation in Clinical Trials

Feb 27, 2019 | Press Releases

Cambridge, MA, February 27, 2019 — Houston Methodist Hospital, a leading academic medical center in Texas that fosters innovation for potential clinical application, is joining the TriNetX global health research network to enhance its ability to provide real-world...

TriNetX Unveils Intuitive and Scalable Treatment Pathways Analytic Powered by Its Global Network of Longitudinal Real-World Data

Feb 19, 2019 | Press Releases

Orlando, FL – SCOPE Summit – February 19, 2019 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the release of its Treatment Pathways...

TriNetX Streamlined, Flexible Data Management with Snowflake Data Sharing

Feb 5, 2019 | Press Releases

The only data warehouse built for the cloud enables TriNetX to efficiently store and share data from over 300M patients across 16 countries, delivering customers speed-of-thought healthcare insights SAN MATEO, Calif. – February 5, 2019 – Snowflake Computing, the only...

University Hospitals Cleveland Medical Center Leverages TriNetX to Assess Study Feasibility & Foster Research Collaborations

Jan 7, 2019 | Press Releases

Cambridge, MA, January 7, 2019 — University Hospitals (UH) Cleveland Medical Center, a 1,032-bed, tertiary medical centerin Northern Ohio, has joined the TriNetX global health research network. “Our interest in joining TriNetX is threefold,” said Grace A. McComsey,...

TriNetX Real-World Evidence Platform Validates Outcomes of Randomized Clinical Trials

Dec 18, 2018 | Press Releases

New Cardiovascular Study Affirms Advantages of an Antidiabetic Treatment Class When Treating Patients with Diabetes Cambridge, MA, December 18, 2018 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the...

World Journal of Diabetes – “Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes”

Dec 15, 2018 | Published Research

This study published in the World Journal of Diabetes evaluates the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in a real world setting by analyzing electronic medical records.Manfred Paul Stapff, CMO, TriNetX Inc.,...

ISPOR Europe 2018 – Parkinson’s Disease Study

Nov 12, 2018 | Events, Published Research

This scientific poster investigates the risk of Parkinson’s Disease (PD) in patients taking adrenergic drug treatments. Download the poster...

ISPOR Europe 2018 – Suicidality Study

Nov 12, 2018 | Events, Published Research

This scientific poster is comparing the risk of suicidality in adult versus youth patients treated with serotonin reuptake inhibitors—A real-world evidence-based approach. Download the poster...

ISPOR Europe 2018 – Chronic Kidney Disease Study

Nov 12, 2018 | Events, Published Research

This scientific poster investigates the risk of stroke or systemic embolism in chronic kidney disease patients with atrial fibrillation. Download the poster...
« Older Entries
Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information